Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
Snapshots of community advocacy in high-burden TB countries

At the Union World Conference on Lung Health Thursday, the Global Fund to Fight AIDS, Tuberculosis and Malaria hosted a forum that showcased civil society tuberculosis (TB) advocacy efforts and outlined the Global Fund’s work to ensure the inclusion of civil society in country-level processes related to Fund grant-making.

Published
27 October 2011
From
Science Speaks
Treatment Action Global TB R&D Investment Trends 2010 Funding Flat at $617 million, Less Than One-Third of the Global Need

New data released by the Treatment Action Group (TAG) and the Stop TB Partnership finds that in 2010 the world spent just $617 million in tuberculosis (TB) research and development (R&D), or 0.3% less than 2009 funding levels—the first time TAG documents no growth since it began tracking TB research investments in 2005.

Published
26 October 2011
From
Treatment Action Group
New WHO recommendations on use of commercial TB Interferon-Gamma Release Assays (IGRAs) in low- and middle-income countries

IGRAs are more costly and technically complex to do than the TST. Given comparable performance but increased cost, replacing the TST by IGRAs, as a public health intervention in resource-constrained settings, is not recommended.

Published
25 October 2011
From
WHO
Editorial: Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

Published
20 October 2011
From
New England Journal of Medicine
Integration of Antiretroviral Therapy with Tuberculosis Treatment

Final results of the SAPIT trial comparing initiation of antiretroviral treatment less than four weeks after starting TB treatment to deferring antiretroviral treatment for at least four weeks after starting TB treatment.

Published
20 October 2011
From
New England Journal of Medicine
Earlier versus Later Start of Antiretroviral Therapy in HIV-infected Adults with Tuberculosis

Free full text of the final results of the CAMELIA trial, which showed that starting antiretroviral therapy no more than two weeks after starting TB treatment was associated with improved survival in adults with very advanced HIV disease.

Published
20 October 2011
From
New England Journal of Medicine
Zambian was key to reshaping the global response to HIV

In July, 2004, Winstone Zulu sat on a stage next to Nelson Mandela. At the International AIDS Conference in Bangkok, Winstone and Mandela spoke to delegates about the urgent need for new research into tuberculosis, a disease both of them had survived.

Published
15 October 2011
From
Globe and Mail
HIV and TB activist Winstone Zulu dead

The prominent HIV and TB activist Winstone Zulu has died at the age of 47 in hospital in Lusaka. Mr Zulu was diagnosed with HIV in 1990

Published
12 October 2011
By
Keith Alcorn
WHO warns of consequences of under-funding TB

Although the number of people who fall ill from tuberculosis is beginning to decline, current progress is at risk from under-funding, especially efforts to combat drug-resistant TB, says the World Health Organization.

Published
12 October 2011
From
WHO
WHO Challenges Russia on TB

The World Health Organization has challenged Russia to compete with neighboring countries for the best national plan to fight drug-resistant tuberculosis — and offered money to boot.

Published
12 October 2011
From
Moscow Times

Filter by country